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Abstract: The aim of this systematic review is to evaluate the role of enteral nutrition in 
dementia. The prevalence of dementia is predicted to rise worldwide partly due to an aging 
population. People with dementia may experience both cognitive and physical complications 
that impact on their nutritional intake. Malnutrition and weight loss in dementia correlates 
with cognitive decline and the progress of the disease. An intervention for long term eating 
difficulties is the provision of enteral nutrition through a Percutaneous Endoscopic 
Gastrostomy tube to improve both nutritional parameters and quality of life. Enteral nutrition 
in dementia has traditionally been discouraged, although further understanding of physical, 
nutritional and quality of life outcomes are required. The following electronic databases were 
searched: EBSCO Host, MEDLINE, PubMed, Cochrane Database of Systematic Reviews 
and Google Scholar for publications from 1st January 2008 and up to and including 1st 
January 2014. Inclusion criteria included the following outcomes: mortality, aspiration 
pneumonia, pressure sores, nutritional parameters and quality of life. Each study included 
separate analysis for patients with a diagnosis of dementia and/or neurological disease. 
Retrospective and prospective observational studies were included. No differences in 
mortality were found for patients with dementia, without dementia or other neurological 
disorders. Risk factors for poor survival included decreased or decreasing serum albumin 
levels, increasing age or over 80 years and male gender. Evidence regarding pneumonia was 
limited, although did not impact on mortality. No studies explored pressure sores or quality 
of life. 
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1. Introduction 
Due to a global aging population the incidence and prevalence of dementia is predicted to rise 
worldwide, with an estimated 81 million people diagnosed with dementia by 2040 [1]. Dementia is an 
umbrella term for a number of specific conditions which are progressive in nature and impact on multiple 
areas of functioning including decline in memory, reasoning, communication skills and ability to carry 
out daily activities [2]. 
A common experience for people with dementia is the development of eating difficulties leading to 
problems such as malnutrition and weigh loss [3,4]. The severity and progression of dementia is closely 
related to weight loss [5,6]. In the early stages of dementia eating difficulties are attributed to olfactory 
and taste dysfunction, executive planning difficulties, attention deficits, dyspraxia, agnosia and 
behavioural problems [7]. In advanced stages of dementia oral and pharyngeal phase dysphagia may be 
present leading to the inability to coordinate chewing and swallowing, and disruption of the food bolus 
from the oropharynx into the oesophagus without aspiration [8]. Reduced nutrition has negative 
outcomes for patients with dementia including higher morbidity and mortality, reduced quality of life 
and increased carer burden [9–11]. 
An intervention for long term eating difficulties across different health conditions is the provision of 
enteral nutrition through a Percutaneous Endoscopic Gastrostomy (PEG) tube. The provision of enteral 
nutrition is both to provide complete nutrition and improve the patient’s quality of life [12]. A systematic 
review in 1999 explored the impact of enteral nutrition in patients with advanced dementia and found 
no improvements in the rates of aspiration, pressures sores or mortality [13]. No data was found on 
quality of life, although many complications were reported including: gastric perforation, gastric 
prolapse, aspiration, diarrhoea, gastrointestinal bleeding, nauseas and vomiting, fluid overload and loss 
of social aspects of feeding. Finucane et al. [13] concluded enteral nutrition for patients with dementia 
should be actively discouraged. 
A further review in 2001 explored nutritional parameters, quality of life and mortality of older people 
with dementia receiving enteral nutrition [14]. A small number of studies (n = 3) found improvements 
in nutritional parameters and an increased albumin was associated with decreased mortality. 
Dharmarajan et al. [14] found quality of life was difficult to analyse in this population as patients with 
advanced dementia could not narrate their subjective feelings, and family members reported conflicting 
opinions. Mortality ranged from 11%–27% across studies at 30 days post insertion of a PEG and 
commencement of enteral nutrition. However, mortality was not uniformed: older patients, men and 
patients with an acute illness had higher mortality than women and African-American patients. 
Dharmarajan et al. [14] recommended caution in decisions regarding enteral nutrition in older people 
with dementia. 
A more recent review in 2009 reported no significant association between enteral nutrition and 
decreased mortality in older patients with dementia [15]. Secondary outcomes of weight loss, Body Mass 
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Index (BMI), haemocrit and cholesterol were not significantly different between those receiving enteral 
nutrition to those who were not, albumin levels were significantly decreased in patients receiving enteral 
nutrition [15]. No studies in this review explored the impact of enteral nutrition on quality of life, 
behavioural or psychiatric symptoms of dementia. However, one study documented the use of restraint, 
with 71% of patients being physically restrained to prevent removal of a PEG compared to 55% of those 
not receiving enteral nutrition [16]. Sampson et al. [15] conclude that there is insufficient evidence to 
suggest enteral nutrition in patients with advanced dementia is beneficial. 
Clinical guidance reflects the evidence to date, National Institute for Health and Care Excellence 
(NICE) guidance [17] suggests enteral nutrition may be considered if dysphagia in a patient with 
dementia is deemed to be transient, but should not generally be used for patients with advanced dementia 
who are disinclined to eat or have permanent dysphagia. European Society of Parenteral and Enteral 
Nutrition (ESPEN) are shortly to realise their guidelines on Nutrition in Dementia [7]. ESPEN confirm 
the use of enteral nutrition in patients with mild or moderate dementia if malnutrition is predominantly 
the cause of a reversible condition and only for a limited time. Reversible conditions are secondary 
concurrent illnesses such as depression, infection, over use of sedatives, pain or poor oral health. ESPEN 
do not recommend the use of enteral nutrition in the terminal phase of dementia, although acknowledge 
decisions are unique for each patient with dementia and should take into consideration the patient’s 
general prognosis and preferences. 
Decisions regarding enteral nutrition in advanced dementia remain ethically challenging for all 
involved [4]. One challenge is the possible complications of enteral nutrition including aspiration 
pneumonia and fluid overload [13,18]. Further challenges include understanding the patient’s wishes as 
they may be unable to communicate and are unlikely to have documented their wishes through advance 
directives or advance care plans [19,20]. 
However, evidence suggests the continued use of enteral nutrition in the older population with dementia. 
A study in the United States found 34% of nursing home residents received enteral nutrition [21] and 
30% of PEG insertions were estimated to be in people with dementia [22]. In Japan, elderly people 
receiving enteral nutrition is on the increase [23]. Many studies and reviews have been completed 
exploring the immediate clinical effects of enteral nutrition for people with advanced dementia [13–15,24]. 
However, methodologies, focus and outcomes of these studies have begun to change and the need to 
explore further risk factors for patients with dementia receiving enteral nutrition is required. Therefore 
the aim of this review is to explore recent data on both physical and nutritional outcomes and the impact 
on quality of life of patients with dementia receiving enteral nutrition. 
Objectives: • Evaluate the impact of enteral nutrition on mortality, risk factors for mortality, pressure sores, 
aspiration pneumonia and nutritional parameters for patients with dementia. • Evaluate the impact of enteral nutrition on quality of life for patients with dementia. 
2. Experimental Section 
Published guidelines [25,26] were used to complete a systematic review. An initial scoping exercise 
identified three relevant systematic reviews [13–15], which informed the criteria for the search. The 
following electronic databases were searched: EBSCO Host, MEDLINE, PubMed, Cochrane Database of 
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Systematic Reviews and Google Scholar for publications from 1st January 2008 and up to and including 
1st January 2014. Search words included enteral nutrition, enteral feeding, artificial nutrition, artificial 
nutrition, percutaneous endoscopic gastrostomy and dementia, with and/or Boolean operators (refer to 
Table 1 Literature Search Strategy). All searchers were limited to “English Language”. In addition 
bibliographies of identified articles were manually searched for relevant studies. 
Table 1. Literature Search Strategy. 
Key Words 
Search 
Engine 
Hits 
Search 
Engine 
Hits 
Search 
Engine  
Hits 
Search 
Engine 
Hits 
Search 
Engine 
Hits 
enteral nutrition 
‘and’ dementia 
EBSCO 
Host 
168 PubMed 100 MEDLINE 317 
COCHRANE 
DATABASE 
3 
GOOGLE 
SCHOLAR 
5630 
enteral feeding 
‘and’ dementia 
EBSCO 
Host 
62 PubMed 102 MEDLINE 324 
COCHRANE 
DATABASE 
3 
GOOGLE 
SCHOLAR 
4380 
enteral feeding 
‘and’ dementia 
patients 
EBSCO 
Host 
13 PubMed 63 MEDLINE 324 
COCHRANE 
DATABASE 
3 
GOOGLE 
SCHOLAR 
4510 
artificial 
nutrition ‘and’ 
dementia 
EBSCO 
Host 
96 PubMed 39 MEDLINE 98 
COCHRANE 
DATABASE 
1 
GOOGLE 
SCHOLAR 
14,300 
nasogastric tube 
‘and’ dementia 
EBSCO 
Host 
14 PubMed 0 MEDLINE 38 
COCHRANE 
DATABASE 
2 
GOOGLE 
SCHOLAR 
16,100 
percutaneous 
endoscopic 
gastrostomy 
‘and’ dementia 
EBSCO 
Host 
2 PubMed 78 MEDLINE 124 
COCHRANE 
DATABASE 
2 
GOOGLE 
SCHOLAR 
2330 
artificial feeding 
‘and’ dementia 
EBSCO 
Host 
30 PubMed 354 MEDLINE 947 
COCHRANE 
DATABASE 
1 
GOOGLE 
SCHOLAR 
18,500 
2.1. Inclusion and Exclusion Criteria 
In addition to the search strategy above the inclusion criteria were: measured outcomes of mortality, 
aspiration pneumonia, pressure sores, nutritional parameters and quality of life, and a separate analysis 
of patients with a primary diagnosis of dementia or neurological disease. Exclusion criteria were: 
administration of enteral nutrition via nasogastric tubes, intravenous fluids and short term interventions. 
Two studies were excluded as analysis combined the outcomes of patients with dementia receiving 
enteral nutrition via a nasogastric tubes and PEG tubes [27,28]. 
3. Results 
A total of five studies were included in the systematic review and all had an observational design. 
Two studies applied a prospective design [29,30] and three studies applied a retrospective design [31–33]. 
Studies were completed in Japan [31], USA [32], Sweden [29,33] and Germany [30]. Study sample sizes 
ranged from 119–484, participants were categorized with a diagnosis of dementia [31,33] or a broader 
definition of dementia as significant cognitive impairment and/or combined with other neurologic  
disorders [29,30,32]. All studies included enteral nutrition administered via PEG tubes. All studies 
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included mortality following the commencement of enteral nutrition or the insertion of a PEG. Mortality 
was analysed using Kapan-Meirer analysis, which is an estimate of the number of participants who survive 
for a certain amount of time following a healthcare intervention [34]. Secondary outcomes included 
predictors of mortality, serum albumin levels, aspiration pneumonia and general complications. No  
studies reported outcomes relevant to pressure sores or quality of life (refer to Table 2 Summary of 
studies reviewed). 
3.1. Mortality 
Kaplan-Meirer survival analysis were completed by all five studies [29–33]. No significant 
differences in mortality were demonstrated in two studies when patients with dementia were compared 
to those without dementia or other neurological conditions [31–33]. Decreased mortality for patients with 
dementia was demonstrated by one study when compared to patients with stroke, malignant diseases and 
other neurological conditions [33]. Increased mortality for patients with dementia and other neurological 
diseases was a significant finding in two studies [20,30] when compared to patients with tumours. 
3.2. Predictors of Mortality 
A low or decreasing serum albumin was a predictive factor of increased mortality in three  
studies [29,31,32]. Increasing age, or age over 80 years were predictive factors of increased mortality in 
four studies [29,31–33]. Further risk factors identified by individual studies included male [31],  
an additional diagnosis of chronic heart failure [31] and a raised CRP [29]. 
3.3. Pressure Sores 
No studies included in the review explored the impact of enteral nutrition and pressure sore 
development and healing. 
3.4. Aspiration Pneumonia 
Pneumonia including aspiration pneumonia was explored by three studies [30–32]. Rates of 
pneumonia whilst receiving enteral nutrition via a PEG tube was 5% and was not a risk factor of 
mortality [30–32]. One study reported aspiration pneumonia rates were comparable across patients with 
dementia and those without dementia receiving enteral nutrition [31]. One study reported pneumonia 
rates, not linked to aspiration were comparable across patients with neurologic conditions and tumours 
receiving enteral nutrition.  
3.5. Quality of Life 
No studies included in the review explored the impact of enteral nutrition and quality of life for 
patients with dementia.  
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Table 2. Summary of Studies Reviewed. 
Author 
Study, Design,  
Country of Study 
Population Size Age Mean SD 
Kaplan-Meier  
Survival Analysis 
Predictors for Poor Survival 
Higaki et al. 
2008 [31] 
Retrospective study of PEG 
enteral nutrition  
 
Compared outcomes of patients 
with and without dementia in  
the elderly  
 
Japan 
311  
46.0% (n = 143)  
with dementia  
54.0% (n = 168)  
without dementia  
78.8 
83.7 ± 8  
with dementia  
78.8 ± 11  
without dementia 
No significant difference 
in mortality between 
patients with dementia 
and those without 
dementia (p = 0.62) 
-subtotal gastrectomy  
(OR 2.619, 95% CI: 1.367–5.019)  
-serum albumin < 2.8 g/dL  
(OR 2.081, 95% CI: 1.490–2.905)  
-age > 80 years  
(OR 1.721, 95% CI: 1.234–2.399)  
-chronic heart failure  
(OR 1.541, 95% CI: 1.096–2.168)  
-male (OR 1.407,  
95% CI: 1.037–1.909) 
Gaines et al. 
2009 [32] 
Retrospective study of PEG 
enteral nutrition  
 
Compared outcomes for patients 
with dementia or significant 
cognitive impairment (SCI) to 
those without these conditions  
 
USA 
190  
23.7% (n = 45)  
dementia or SCI  
76.3% (n = 145)  
without dementia or SCI 
Median age: 64 
No significant difference 
in mortality in patients 
with dementia or SCI and 
those without (p = 0.85) 
Predictors for 30-day mortality  
-increasing age  
(OR 1.08, 95% CI: 1.04–1.12)  
-decreasing serum albumin  
(OR 0.43, 95% CI: 0.22–0.84) 
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Table 2. Cont. 
Author Study Design Country of Study Population Size Age Mean SD 
Kaplan-Meier  
Survival Analysis 
Predictors for Poor Survival 
Malmgren et 
al. 2011 [33] 
Retrospective study of PEG 
enteral nutrition  
 
Indications for survival after PEG 
insertion in patients older than 65  
 
Sweden 
191  
8.4% (n = 16) dementia  
5.8% (n = 11) Parkinson  
9.5% (n = 19) miscellaneous  
49.7% (n = 95) stroke  
18.4% (n = 35) malignant  
6.8% (n = 13) neurological 
diseases 
79.0 ± 7 
Patients with dementia or 
Parkinsons had longest 
median survival 
-patients with dementia >80 years of 
age than those with dementia  
<80 years of age (p = 0.025) 
Blomberg et al. 
2012 [29] 
Observational prospective study 
of PEG enteral nutrition  
 
Outcome of patients following 
PEG insertion  
 
Sweden 
484  
44% (n = 214) tumours  
45% (n = 218) neurological 
disease including dementia 
66.0 ± 14 
Mortality higher in 
patients with neurological 
disorders than those with 
tumours (p = 0.002) 
-serum albumin < 30 g/L (hazard 
ration (HR), 3.46; 95% CI 1.75–6.88)  
-CRP ≥ 10 (HR, 3.47;  
95% CI 1.68–7.18)  
-age ≥ 65 (HR, 2.26;  
95% CI 1.20–4.25) 
Schneider et al. 
2014 [30] 
Observational prospective study 
of PEG enteral nutrition  
 
Outcomes of patients following 
PEG insertion  
 
Germany 
119  
57.2% (n = 68) tumours  
29.4% (n = 35) neurologic  
including dementia  
13.4% (16) other 
63.0 ± 13 
Mortality higher in 
patients with neurological 
disorders than those with 
tumours (p = 0.002) 
NA 
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4. Discussion 
In this review, the impact of enteral nutrition on mortality was equivalent for patients with dementia, 
without dementia or diagnosed with other neurological conditions. However, patients with dementia had 
decreased mortality compared to patients with a stroke and increased mortality compared to patients 
with tumours. Risk factors for poor survival included decreased or decreasing serum albumin levels, 
increasing age or over 80 years, and male gender. Limited evidence on pneumonia was found, although 
did not impacted on mortality. No studies explored the development or healing of pressure sores or 
quality of life. 
Previous studies have failed to demonstrate enteral nutrition for patients with dementia prolongs 
survival [18,35–37]. Current studies suggest mortality of patients with dementia receiving enteral 
nutrition when compared to other conditions is dependent on the comparativeness of these conditions, 
including stage of the disease and long term prognosis. The importance of the timing of the decision 
with regards to the prognosis of the patient with dementia may be an influential factor, as enteral nutrition 
is more frequently commenced in advanced dementia [33]. Patients with advanced dementia may exhibit 
a low level of functionality over a long period of time, which contributes to general frailty [38]. Illness 
trajectories and mortality in dementia are difficult to predict due to low functionality and frailty, which 
leads to discussions regarding enteral nutrition in the advanced stages of dementia as end of life is 
difficult to recognize [38,39]. Therefore, the possibility of some studies to include older patients with 
more advanced dementia and the tendency to commence enteral nutrition in the late stages of the disease 
process may have implications for mortality rates. 
In the current review a decreased or decreasing serum albumin was a predictor of mortality [29,31,32]. 
Decreased serum albumin levels (<3.0 mg/dL) have been associated with increased mortality in enteral 
nutrition where analysis did not differentiate the diagnosis of patients [40,41]. Evidence for the impact 
of the diagnosis of dementia and decreasing serum albumin levels for patients receiving enteral nutrition 
is inconsistent. One study found serum albumin levels did not predict survival in patients with dementia, 
but did predict survival in patients without dementia receiving enteral nutrition [42]. The impact of serum 
albumin levels in patients not receiving enteral nutrition needs to be considered, as decreased serum 
albumin in critical illness was associated with increased mortality [43]. In the healthy elderly serum 
albumin levels decreased with age and were predictive of mortality independent of know disease [44]. 
Evidence regarding decreased or decreasing serum albumin levels suggests an impact on mortality and 
therefore, needs to be considered in the provision of enteral nutrition regardless of diagnosis but with 
consideration of age. 
Aspiration pneumonia has been a recognised complication of advanced dementia and enteral nutrition 
administered via PEG tubes [3]. Finucane et al. [13] reported no randomised controlled trials had 
explored the reduction of aspiration pneumonia following the provision of enteral nutrition via a PEG 
tube. In the current review one observational study reported aspiration pneumonia occurrence at 5%, 
which was comparable for patients with and without dementia and was not a risk factor of mortality [31]. 
Tentatively enteral nutrition delivered through a PEG tube does not increase the risk of aspiration for 
patients with dementia compared to rates of aspiration pneumonia of other disease cohorts. 
The development and healing of pressure sores was not explored by the studies included in this review. 
However, Martin et al. [27] explored the impact of enteral nutrition administered via nasogastric tubes and 
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PEG tubes reported pressure and reported that a fifth of patients developed a pressure sore during the 
provision of enteral nutrition, and the healing of pressure sores was correlated with increased mortality. The 
development and lack of healing of pressure sores may correlate with hypoalbuminemia, as this is a risk 
factor for the development of pressure sores and increases resistance to treatment [45,46]. No further studies 
have explored the correlation between serum albumin and pressure sores in patients with dementia receiving 
enteral nutrition. Martin et al. [27] reported enteral nutrition in patients with dementia was effective in 
preserving but not significantly improving serum albumin levels. 
Limitations of the studies included in this review need to be acknowledged. Different clinical 
practices and guidelines across continents may impact on the results of studies included. Practices across 
continents were difficult to identify only three studies reported PEG placement procedures and none 
clarified/defined enteral nutrition. Prevalence of enteral nutrition in patients with dementia in Japan may 
be higher than Western populations due to current guidelines. In Japan guidelines compiled under the 
supervision of the Japan Gastroenterology Endoscopy Society recommend PEG insertion for patients 
who cannot maintain their nutrition due to cerebrovascular disease or dementia [47]. The impact of these 
guidelines may be the earlier insertion of PEG tubes and the commencement of enteral nutrition in patients 
with dementia leading to longer survival rates [31]. Higaki et al. [31] reported survival at  
12 months of 51% for patients with dementia of which 20% were still alive three years, compared to 
41% of patients with dementia at 12 months in a study completed in Sweden [33]. However,  
no longitudinal data was reported outside Japan and the challenges to this guidance and Japanese health-
care system reforms may impact on this prevalence [28]. 
Further limitations of the studies include small sample sizes and different categorization of conditions. 
Dementia was categorized as a separate neurological condition in some studies, but included with other 
neurological conditions in further studies. Diagnosis was generalised in some studies to those with and 
without dementia, and more detailed in further studies with all conditions categorized and therefore, 
direct comparison and interpretation of results is difficult. 
Ethical considerations of insertion of a PEG in a patient with dementia are important. ESPEN and 
NICE guidelines do not recommend enteral nutrition in patients with advanced dementia and only 
occasionally in patients in the earlier stages of dementia. Enteral nutrition is recommended only to ensure 
adequate provision of nutritional needs, when under-nutrition is caused by reversible conditions other 
than the dementia [48]. However, diagnostic overshadowing, a tendency to attribute all symptoms to 
dementia thereby leaving a co-existing conditions undiagnosed has been recognised and needs to be 
continually challenged [49]. 
Alzheimer’s Society supports the importance of quality of life rather than length of life. For the person 
with dementia decreased quality of life has been associated with behavioural and psychological disturbances, 
but no associations with dysphagia or cognition has been demonstrated to date [50]. A recent a recent review 
by the Royal College of Physicians suggests the need for reluctance to commence enteral nutrition in 
dementia, however state this cannot be translated into a blanket ban [51]. A decision-making algorithm 
integrating medical and ethic dimensions regarding enteral nutrition in dementia has been developed and 
may be helpful to healthcare professionals faced with this ethical dilemma [52]. 
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5. Conclusions 
The studies included in this systematic review challenge the traditional view that enteral nutrition 
administered through a PEG tube increases mortality in patients with dementia. The recommendations 
from this review include the need for a holistic assessment of patients with dementia when contemplating 
PEG insertion and enteral nutrition. A holistic assessment would include: the patients’ diagnosis 
including comorbidities, current stage and impact of dementia on the need for enteral nutrition, age and 
nutritional parameters. The impact of enteral nutrition on quality of life for patients with dementia 
remains unclear, although complications are acknowledged. Enteral nutrition within end of life care is 
not recommended, although this review acknowledges recognising end of life within dementia is 
problematic. A further recommendation is early discussions with patients with dementia and their family 
regarding nutrition needs in advanced dementia and the documentation of the results of these 
discussions. However, decision making regarding PEG insertion and enteral nutrition in patients with 
dementia currently remains ethically challenging and should involve discussions around appropriate end 
of life care. 
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